4.5 Article

The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model

Journal

OSTEOPOROSIS INTERNATIONAL
Volume 28, Issue 1, Pages 127-137

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s00198-016-3766-5

Keywords

Age dependent intervention threshold; Fixed intervention threshold; FRAX; Guidelines; Osteoporosis

Funding

  1. American University of Beirut, Lebanon
  2. Fogarty International Center
  3. Office of Dietary Supplements of the National Institutes of Health [D43 TW009118]

Ask authors/readers for more resources

We describe our approach to develop FRAX-based osteoporosis treatment guidelines in Lebanon, a country with low-moderate fracture rates. A hybrid assessment algorithm that combines a fixed 10 % intervention threshold until age 70 years, and an age-dependent threshold thereafter, was deemed most suitable. The FRAX risk calculator is used to guide intervention thresholds in several national osteoporosis guidelines. This study aimed to describe the approach in developing FRAX-based osteoporosis treatment guidelines in Lebanon, a country with relatively low fracture rates. We reassessed previous national guidelines combined with an evaluation of age-dependent and fixed FRAX-based intervention threshold models used in the UK, the USA, and Canada. We took into consideration the risk for major osteoporotic fractures (MOF) and the proportions of subjects considered for therapy using such thresholds, before finalizing a model for Lebanon. The new Lebanese guidelines retained the recommendation to treat individuals with fragility fracture at the hip or spine. A femoral neck T-score ae-2.5 in subjects without fractures was dropped, since it would imply consideration of therapy for individuals with a 10-year risk for MOF of < 10 %, up to age 75 years in women. After considering the impact of both age-dependent and fixed intervention thresholds, we chose a new hybrid algorithm, combining a fixed 10 % treatment threshold until age 70 years and an age-dependent threshold thereafter. The Lebanese FRAX-based hybrid model takes into consideration the risk for MOF and the proportions of subjects considered for treatment. This model avoids consideration of drug therapy in a large proportion of younger subjects at low risk for fracture and targets high risk elderly individuals. It was deemed most suitable for Lebanon and may be an option for other countries with relatively low fracture rates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Performance of FRAX in Men With Prostate Cancer: A Registry-Based Cohort Study

Carrie Ye, Suzanne N. Morin, Lisa M. Lix, Eugene V. McCloskey, Helena Johansson, Nicholas C. Harvey, John A. Kanis, William D. Leslie

Summary: The study assessed the performance of the Fracture Risk Assessment Tool (FRAX) in predicting incident fractures in men with prostate cancer. The results showed that FRAX reliably predicts fractures in this population.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Article Endocrinology & Metabolism

Hormones and Aging: An Endocrine Society Scientific Statement

Anne R. Cappola, Richard J. Auchus, Ghada El-Hajj Fuleihan, David J. Handelsman, Rita R. Kalyani, Michael McClung, Cynthia A. Stuenkel, Michael O. Thorner, Joseph G. Verbalis

Summary: Multiple changes occur in various endocrine systems as individuals age. The understanding of age-related changes and their clinical management is developing. This statement reviews the current research in different endocrine axes and conditions specific to older individuals, including available therapies, clinical trials, key points, and scientific gaps. The goal is to inform future research to improve prevention and treatment strategies for age-associated endocrine conditions in older individuals.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension

Didier Hans, Michele McDermott, Shuang Huang, Min Kim, Enisa Shevroja, Michael McClung

Summary: Up to 10 years of denosumab treatment significantly improved bone microarchitecture in postmenopausal women with osteoporosis, independently of bone mineral density. The treatment also decreased the number of high fracture-risk patients and shifted more patients to lower fracture-risk categories.

OSTEOPOROSIS INTERNATIONAL (2023)

Review Medicine, General & Internal

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation

Marlene Chakhtoura, Rachelle Haber, Malak Ghezzawi, Caline Rhayem, Raya Tcheroyan, Christos S. Mantzoros

Summary: Obesity is a widespread health issue and medical weight management has seen significant advancements in recent years, leading to improved treatment options. Various medications have been approved for the management of obesity and there are promising novel drugs being researched.

ECLINICALMEDICINE (2023)

Article Endocrinology & Metabolism

Romosozumab Efficacy in Postmenopausal Women With No Prior Fracture Who Fulfill Criteria for Very High Fracture Risk

Michael R. McClung, Donald Betah, Cynthia Deignan, Yifei Shi, Jen Timoshanko, Felicia Cosman

Summary: Romosozumab significantly reduced fracture risk and increased bone mineral density in women at high fracture risk.

ENDOCRINE PRACTICE (2023)

Article Endocrinology & Metabolism

Effect of BMI-Discordant Abdominal Tissue Thickness on Fracture Probability: A Registry-Based Study

William D. Leslie, Neil Binkley, John T. Schousboe, Eugene V. Mccloskey, Helena Johansson, Nicholas C. Harvey, John A. Kanis

Summary: This study found that abdominal thickness has an impact on FRAX-derived major osteoporotic fracture and hip fracture compared to BMI. The effect is stronger before the age of 65 and there is also an increased risk of lower abdominal thickness for individuals with diabetes. These findings suggest the need to investigate abdominal thickness beyond BMI and sex prediction as an independent risk factor for fracture using FRAX.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Article Endocrinology & Metabolism

Effect of Race/Ethnicity on United States FRAX Calculations and Treatment Qualification: A Registry-Based Study

William D. Leslie

Summary: This study investigated differences in FRAX scores among different racial/ethnic groups and explored the impact of using a population-based calculator on treatment qualification for osteoporosis. The study found disparities in treatment qualification using existing US race/ethnic-specific FRAX calculators, while using a population-based calculator could reduce these disparities.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Article Endocrinology & Metabolism

A Population-Based Registry Study of Extended Bisphosphonate Use: Minimal Shift After Landmark Publications About Shorter Treatment Duration

Gregory A. A. Kline, Suzanne N. N. Morin, Lisa M. M. Lix, William D. D. Leslie

Summary: Based on the FLEX study in 2006, a 5-year course of bisphosphonate therapy was found to be sufficient for most women. However, despite the increased risk of atypical femoral fractures associated with long-term use, up to one-third of patients continued to receive bisphosphonate therapy for over 10 years after 2010.

JOURNAL OF BONE AND MINERAL RESEARCH (2023)

Review Endocrinology & Metabolism

Proceedings of the 2023 Santa Fe bone symposium: Progress and controversies in the management of patients with skeletal diseases

E. Michael Lewiecki, Teresita Bellido, John P. Bilezikian, Jacques P. Brown, Azeez Farooki, Christopher S. Kovacs, Brendan Lee, William D. Leslie, Michael R. McClung, Mark L. Prasarn, Deborah E. Sellmeyer

Summary: The 23rd annual Santa Fe Bone Symposium brought together attendees from various states and countries to discuss topics related to osteoporosis and other bone diseases. The event included plenary presentations, panel discussions, workshops, and oral presentations of research abstracts.

JOURNAL OF CLINICAL DENSITOMETRY (2023)

Article Endocrinology & Metabolism

Adjusting Trabecular Bone Score (TBS) for level-specific differences reduces FRAX®-based treatment reclassification in patients with vertebral exclusions: The Manitoba BMD Registry

William D. Leslie, Neil Binkley, Heenam Goel, Didier Hans, Eugene V. McCloskey

Summary: The exclusion of vertebral levels affects the trabecular bone score (TBS) and FRAX-based treatment recommendations. Adjusting for level-specific differences in TBS reduces the reclassification in FRAX-based treatment recommendations.

JOURNAL OF CLINICAL DENSITOMETRY (2023)

Article Endocrinology & Metabolism

Effects of severe lumbar spine structural artifact on trabecular bone score (TBS): The Manitoba BMD Registry

William D. Leslie, Neil Binkley, Didier Hans

Summary: Trabecular bone score (TBS) is an independent risk factor for fracture that is not dependent on bone mineral density (BMD). This study found that TBS is still useful in the presence of extreme structural artifact that affects lumbar spine BMD measurements, but it is significantly affected by the presence of multilevel degenerative changes and/or instrumentation.

JOURNAL OF CLINICAL DENSITOMETRY (2023)

Article Endocrinology & Metabolism

FRAX® adjustment using renormalized trabecular bone score (TBS) from L1 alone may be optimal for fracture prediction: The Manitoba BMD registry

William D. Leslie, Neil Binkley, Heenam Goel, Eugene V. McCloskey, Didier Hans

Summary: The use of FRAX adjusted for lumbar vertebral levels and specifically using only L1 for TBS measurement improves the accuracy of fracture prediction.

JOURNAL OF CLINICAL DENSITOMETRY (2023)

Correction Endocrinology & Metabolism

Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis (Sep, 10.1007/s11154-023-09831-3, 2023)

Andrea Giustina, Luigi di Filippo, Antonio Facciorusso, Robert A. Adler, Neil Binkley, Jens Bollerslev, Roger Bouillon, Felipe F. Casanueva, Giulia Martina Cavestro, Marlene Chakhtoura, Caterina Conte, Lorenzo M. Donini, Peter R. Ebeling, Angelo Fassio, Stefano Frara, Claudia Gagnon, Giovanni Latella, Claudio Marcocci, Jeffrey I. Mechanick, Salvatore Minisola, Rene Rizzoli, Ferruccio Santini, Joseph L. Shaker, Christopher Sempos, Fabio Massimo Ulivieri, Jyrki K. Virtanen, Nicola Napoli, Anne L. Schafer, John P. Bilezikian

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2023)

Review Endocrinology & Metabolism

Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis

Andrea Giustina, Luigi di Filippo, Antonio Facciorusso, Robert A. Adler, Neil Binkley, Jens Bollerslev, Roger Bouillon, Felipe F. Casanueva, Giulia Martina Cavestro, Marlene Chakhtoura, Caterina Conte, Lorenzo M. Donini, Peter R. Ebeling, Angelo Fassio, Stefano Frara, Claudia Gagnon, Giovanni Latella, Claudio Marcocci, Jeffrey I. Mechanick, Salvatore Minisola, Rene Rizzoli, Ferruccio Santini, Joseph L. Shaker, Christopher Sempos, Fabio Massimo Ulivieri, Jyrki K. Virtanen, Nicola Napoli, Anne L. Schafer, John P. Bilezikian

Summary: Bariatric surgery is associated with a decrease in 25(OH) vitamin D levels and increased risk of skeletal complications. Guidelines for assessing and supplementing vitamin D in bariatric patients before and after surgery are lacking. This systematic review and meta-analysis provide recommendations for vitamin D management in bariatric patients based on published experience. Vitamin D levels should be assessed pre- and postoperatively in all bariatric surgery patients, and high-dose supplementation is recommended after surgery.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2023)

Article Nutrition & Dietetics

The Genetic Architecture of Vitamin D Deficiency among an Elderly Lebanese Middle Eastern Population: An Exome-Wide Association Study

Nagham Nafiz Hendi, Marlene Chakhtoura, Yasser Al-Sarraj, Dania Saleh Basha, Omar Albagha, Ghada El-Hajj Fuleihan, Georges Nemer

Summary: The Middle East region has a high prevalence of vitamin D deficiency, particularly among elderly individuals. Genetic studies on vitamin D have focused mostly on European populations, therefore there is a lack of research on the genetic factors affecting elderly people in the Middle East. In this study, we identified novel genomic loci associated with vitamin D levels in elderly Lebanese individuals and confirmed the replication of numerous variants from a European study. Our findings provide new insights into the genetic mechanisms of vitamin D deficiency in elderly Middle Eastern populations and can aid in the development of personalized approaches for its management.

NUTRIENTS (2023)

No Data Available